Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | GRM5 | P41594 | 2/20 | 0.41 |
| ▸ | HSD17B13 | Q7Z5P4 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.35 |
| ▸ | ACHE | P22303 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718295 | 0.80 | CA12 (0.60) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL28933385 | 0.76 | CA12 (0.41) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL24258157 | 0.74 | APP (0.48) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL30493627 | 0.74 | CA12 (0.59) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL722068 | 0.74 | CA12 (0.59) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL2814308 | 0.72 | CA12 (0.49) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL12289090 | 0.72 | CA12 (0.62) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL20489172 | 0.72 | CA12 (0.49) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL10035471 | 0.72 | CA12 (0.49) | CA12CA2CA9CA1ALDH1A1 | |
| SCHEMBL22163466 | 0.72 | GRM5 (0.50) | CA12CA2CA9CA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303493-A1 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | SAN JOSE STATE UNIVERSITY RESEARCH FOUNDATION | 2023-09-28 | — | — | US | disclosed |
| WO-2022036208-A1 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303493-A1 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | CAPG, SLC11A2, CAPRIN1 | CA12 4192/4885CA2 3190/4885CA9 4390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.